Lexette Aerosol, Foam
NDC Package 51862-618-50

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Lexette (halobetasol propionate) aerosols is a medication used to treat certain skin conditions (such as psoriasis). This formulation utilizes a aerosol, foam delivery system. Marketed by Mayne Pharma, this product is identified by NDC 51862-618 and is authorized under FDA application ANDA215266.

Identification & Billing

NDC Package Code
51862-618-50
Package Description
1 CANISTER in 1 CARTON / 50 g in 1 CANISTER
Product Code
51862-618
11-Digit Billing Format
51862061850
Billing Unit
GM - Billing unit of "gram" is used when a product is measured by its weight.
Units Per Package
50 GM
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Lexette
Non-Proprietary Name
Halobetasol Propionate
Substance Name
Halobetasol Propionate
Dosage Form
Aerosol, Foam - A dosage form containing one or more active ingredients, surfactants, aqueous or nonaqueous liquids, and the propellants; if the propellant is in the internal (discontinuous) phase (i.e., of the oil-in-water type), a stable foam is discharged, and if the propellant is in the external (continuous) phase (i.e., of the water-in-oil type), a spray or a quick-breaking foam is discharged.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
HALOBETASOL PROPIONATE .5 mg/g
Pharmacologic Class
Usage Information
This medication is used to treat certain skin conditions (such as psoriasis). Halobetasol helps reduce the itching, redness, scaling, and swelling that can occur with these conditions. This medication is a very strong (super-high potency) corticosteroid.

Regulatory & Marketing

Labeler Name
Mayne Pharma
Product Type
Human Prescription Drug
FDA Application #
ANDA215266
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
08-08-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 51862-618-50 identifies a specific commercial package of 1 canister in 1 carton / 50 g in 1 canister of Lexette, a human prescription drug labeled by Mayne Pharma. This product is billed per "GM" gram and contains an estimated amount of 50 billable units per package. This aerosol, foam is formulated for topical use and contains halobetasol propionate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Mayne Pharma on August 08, 2025. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used to treat certain skin conditions (such as psoriasis). Halobetasol helps reduce the itching, redness, scaling, and swelling that can occur with these conditions. This medication is a very strong (super-high potency) corticosteroid.

How is this Mayne Pharma product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 51862061850. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 50 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
51862-618-50
11-Digit CMS (5-4-2)
51862-0618-50

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.